FAEGRE DRINKER BIDDLE & REATH LLP

Lobbying registrant · 12631

84 filings on record; a reported $1,700,000 in total across them. Honesty note: each amount is the registrant's reported lobbying income/spend for that quarter (a lump sum required by the Lobbying Disclosure Act, or LDA — the law governing public lobbying reports), so this total is a gross sum of quarterly figures. The filings do disclose which bills were lobbied on (below), but never how much of the money went to any one bill, and never whether the filer supported or opposed it.

Clients

Filings

ClientPeriodReported quarterly amountFiling type
SARGENTO FOODS INC. Q2 2026 $30,000 Q2
ILLINOIS INSTITUTE OF TECHNOLOGY (ILLINOIS TECH) Q2 2026 $20,000 2T
IFB SOLUTIONS Q2 2026 $20,000 Q2
DMG MORI FEDERAL SERVICES Q2 2026 $40,000 Q2
NAVITUS Q2 2026 $40,000 Q2
CUREPSP, INC. Q2 2026 $10,000 Q2
VERDE ENVIRONMENTAL TECHNOLOGIES, INC. Q2 2026 not reported Q2Y
PARENT PROJECT MUSCULAR DYSTROPHY Q2 2026 $30,000 Q2
MATHEMATICAL ASSOCIATION OF AMERICA Q2 2026 $20,000 Q2
LUPUS FOUNDATION OF AMERICA Q2 2026 not reported Q2Y
IVY TECH COMMUNITY COLLEGE Q2 2026 $30,000 Q2
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS Q2 2026 $30,000 Q2
COPD FOUNDATION Q2 2026 $30,000 Q2
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER Q2 2026 $30,000 Q2
AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE Q2 2026 $20,000 Q2
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) Q2 2026 $60,000 Q2
THE CHICAGO SCHOOL Q2 2026 $30,000 Q2
TEVA PHARMACEUTICALS USA, INC. Q2 2026 $60,000 Q2
THE NATIONAL SOCIETY OF GENETIC COUNSELORS Q2 2026 $60,000 Q2
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY Q2 2026 $20,000 Q2
NE HEALTHCARE SERVICES, INC. Q2 2026 $10,000 Q2
AMERICAN ACADEMY OF NEUROLOGY Q2 2026 $40,000 Q2
NATIONAL ORGANIZATION OF LIFE AND HEALTH INSURANCE GUARANTY ASSOCIATIONS Q2 2026 not reported Q2Y
NATIONAL CONFERENCE OF INSURANCE GUARANTY FUNDS Q2 2026 not reported Q2Y
ATHENE USA Q2 2026 not reported Q2Y
SSM HEALTH Q2 2026 $30,000 Q2
CROHN'S & COLITIS FOUNDATION Q2 2026 $20,000 Q2
CHILDREN'S HOSPITAL COLORADO Q2 2026 $30,000 Q2
BOSTON CHILDREN'S HOSPITAL Q2 2026 $30,000 Q2
SOLIDARITY HEALTHSHARE Q2 2026 not reported Q2Y
COALITION FOR PEDIATRIC MEDICAL RESEARCH Q2 2026 $40,000 Q2
EVERYLIFE FOUNDATION FOR RARE DISEASES Q2 2026 $30,000 Q2
IMMUNE DEFICIENCY FOUNDATION Q2 2026 $30,000 Q2
ALLINA HEALTH SYSTEM Q2 2026 $40,000 Q2
INTERNATIONAL PHARMACEUTICAL AEROSOL CONSORTIUM Q2 2026 not reported Q2Y
CHINESE AMERICAN SERVICE LEAGUE Q2 2026 not reported RR
GUNVOR USA, LLC Q2 2026 not reported 2T
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS Q1 2026 $10,000 1T
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) Q1 2026 $50,000 Q1
NATIONAL ORGANIZATION OF LIFE AND HEALTH INSURANCE GUARANTY ASSOCIATIONS Q1 2026 not reported Q1Y
NATIONAL CONFERENCE OF INSURANCE GUARANTY FUNDS Q1 2026 not reported Q1Y
ATHENE USA Q1 2026 not reported Q1Y
NAVITUS Q1 2026 $20,000 Q1
IMMUNE DEFICIENCY FOUNDATION Q1 2026 $20,000 Q1
CHILDREN'S HOSPITAL COLORADO Q1 2026 $30,000 Q1
BOSTON CHILDREN'S HOSPITAL Q1 2026 $20,000 Q1
SOLIDARITY HEALTHSHARE Q1 2026 not reported Q1
SSM HEALTH Q1 2026 $30,000 Q1
EVERYLIFE FOUNDATION FOR RARE DISEASES Q1 2026 $40,000 Q1
COALITION FOR PEDIATRIC MEDICAL RESEARCH Q1 2026 $40,000 Q1
CROHN'S & COLITIS FOUNDATION Q1 2026 $30,000 Q1
ALLINA HEALTH SYSTEM Q1 2026 $20,000 Q1
VERDE ENVIRONMENTAL TECHNOLOGIES, INC. Q1 2026 not reported Q1Y
PARENT PROJECT MUSCULAR DYSTROPHY Q1 2026 $30,000 Q1
MATHEMATICAL ASSOCIATION OF AMERICA Q1 2026 $20,000 Q1
LUPUS FOUNDATION OF AMERICA Q1 2026 not reported Q1Y
IVY TECH COMMUNITY COLLEGE Q1 2026 $30,000 Q1
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS Q1 2026 $30,000 Q1
COPD FOUNDATION Q1 2026 $30,000 Q1
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES Q1 2026 not reported 1TY
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER Q1 2026 $30,000 Q1
AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE Q1 2026 $20,000 Q1
TURQUOISE HEALTH CO. Q1 2026 not reported 1TY
THE NATIONAL SOCIETY OF GENETIC COUNSELORS Q1 2026 $60,000 Q1
THE CHICAGO SCHOOL Q1 2026 $30,000 Q1
TEVA PHARMACEUTICALS USA, INC. Q1 2026 $60,000 Q1
NE HEALTHCARE SERVICES, INC. Q1 2026 $10,000 Q1
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY Q1 2026 $30,000 Q1
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) Q1 2026 $10,000 1T
AMERICAN ACADEMY OF NEUROLOGY Q1 2026 $10,000 Q1
SARGENTO FOODS INC. Q1 2026 $20,000 Q1
RUMMO Q1 2026 not reported 1T
ILLINOIS INSTITUTE OF TECHNOLOGY (ILLINOIS TECH) Q1 2026 $20,000 Q1
IFB SOLUTIONS Q1 2026 $20,000 Q1
GUNVOR USA, LLC Q1 2026 not reported Q1
DMG MORI FEDERAL SERVICES Q1 2026 $40,000 Q1
DELALLO Q1 2026 not reported 1TY
CUREPSP, INC. Q1 2026 $10,000 Q1
INTERNATIONAL PHARMACEUTICAL AEROSOL CONSORTIUM Q1 2026 not reported Q1Y
THE REHABILITATION INNOVATION CENTERS COALITION Q1 2026 not reported 1TY
MATHEMATICAL ASSOCIATION OF AMERICA Q1 2026 not reported RR
AMERICAN ACADEMY OF NEUROLOGY Q1 2026 not reported RR
GUNVOR USA, LLC Q1 2026 not reported RR
ALLINA HEALTH SYSTEM Q1 2026 not reported RR

Source: Senate LDA filings.

Bills lobbied on

Bills named in this registrant's filings. A titled link means the bill is in our corpus; a bare canonical reference means it is not.

  • A bill to provide for reconciliation pursuant to title II of H. Con. Res. 14. (us-119-hr-1)
  • us-119-hr-1394 (not in corpus)
  • us-119-hr-1509 (not in corpus)
  • us-119-hr-1650 (not in corpus)
  • us-119-hr-1708 (not in corpus)
  • us-119-hr-1843 (not in corpus)
  • us-119-hr-2062 (not in corpus)
  • us-119-hr-2332 (not in corpus)
  • SUPPORT for Patients and Communities Reauthorization Act (us-119-hr-2483)
  • us-119-hr-2804 (not in corpus)
  • us-119-hr-3432 (not in corpus)
  • CONNECT for Health Act of 2025 (us-119-hr-4206)
  • us-119-hr-508 (not in corpus)
  • Safe Step Act (us-119-hr-5509)
  • us-119-hr-6280 (not in corpus)
  • SAFE Drugs Act of 2025 (us-119-hr-6509)
  • us-119-hr-929 (not in corpus)
  • us-119-s-1087 (not in corpus)
  • us-119-s-1095 (not in corpus)
  • us-119-s-1096 (not in corpus)
  • us-119-s-1097 (not in corpus)
  • us-119-s-1101 (not in corpus)
  • us-119-s-1261 (not in corpus)
  • us-119-s-184 (not in corpus)
  • us-119-s-2544 (not in corpus)
  • us-119-s-2656 (not in corpus)
  • us-119-s-2709 (not in corpus)
  • us-119-s-2903 (not in corpus)
  • us-119-s-3607 (not in corpus)
  • us-119-s-3651 (not in corpus)
  • SAFE Drugs Act of 2026 (us-119-s-3794)
  • us-119-s-43 (not in corpus)
  • us-119-s-653 (not in corpus)
  • us-119-s-752 (not in corpus)
  • us-119-s-763 (not in corpus)

Bill references are free-text extractions from LDA specific_issues; they show a bill was named in a quarter, not money spent on it.

Lobbying ≠ campaign money. These LDA lobbying figures are a separate, unbridged channel from FEC campaign contributions; this platform does not yet link a lobbying registrant to any FEC committee. See the methodology glossary.